- TTNP Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
10-K/A Filing
Titan Pharmaceuticals (TTNP) 10-K/A2004 FY Annual report (amended)
Filed: 15 Apr 05, 12:00am
EXHIBIT 23.2
CONSENT OF ERNST & YOUNG LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements on Forms S-8 No. 333-42533, No. 333-86001, No. 333-62734 and No. 333-100011 (pertaining to the 1995 Stock Option Plan and the 1998 Stock Option Plan, as amended and restated, and the 2002 Stock Option Plan), and Forms S-3 No. 333-33710, No. 333-51250, No. 333-53538, No. 333-112513 and No. 115281 of Titan Pharmaceuticals, Inc. of our report dated February 20, 2004 with respect to the consolidated financial statements of Titan Pharmaceuticals, Inc. as of December 31, 2003 and for the two years then ended included in this Annual Report (Form 10-K/A) for the year ended December 31, 2004.
/s/ ERNST & YOUNG LLP
Palo Alto, California
April 14, 2005
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.